We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
-8.14%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.56B
AUM Growth
-$1.36B
Cap. Flow
-$1.11B
Cap. Flow %
-31.07%
Top 10 Hldgs %
29.11%
Holding
1,521
New
512
Increased
155
Reduced
168
Closed
620

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$193M
2
AMZN icon
Amazon
AMZN
+$126M
3
AMD icon
Advanced Micro Devices
AMD
+$77.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$49.2M
5
XYZ
Block Inc
XYZ
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 2.48%
2 Consumer Discretionary 1.2%
3 Communication Services 1.16%
4 Technology 1.08%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
426
PUT
Fate Therapeutics
FATE
$293M
$1.16M 0.03%
30,000
CTXS
427
CALL
DELISTED
Citrix Systems Inc
CTXS
$1.16M 0.03%
11,500
-38,300
-77% -$3.87M
TCOM icon
428
PUT
Trip.com Group
TCOM
$29.3B
$1.16M 0.03%
+50,000
New +$1.26M
HWM icon
429
Howmet Aerospace
HWM
$111B
$1.15M 0.03%
32,000
+24,000
+300% +$819K
SKIN icon
430
CALL
SkinHealth Systems
SKIN
$87.6M
$1.14M 0.03%
67,500
RYN icon
431
Rayonier
RYN
$6.43B
$1.13M 0.03%
+30,311
New +$1.08M
PXD
432
DELISTED
Pioneer Natural Resource Co.
PXD
$1.13M 0.03%
+4,500
New +$1.02M
PLAY icon
433
PUT
Dave & Buster's
PLAY
$377M
$1.12M 0.03%
22,900
+16,600
+263% +$664K
KLIC icon
434
CALL
Kulicke & Soffa
KLIC
$4.62B
$1.12M 0.03%
20,000
BBIO icon
435
CALL
BridgeBio Pharma
BBIO
$16.1B
$1.12M 0.03%
110,000
-7,700
-7% -$79K
HTZ icon
436
PUT
Hertz
HTZ
$524M
$1.11M 0.03%
+50,000
New +$1.05M
CC icon
437
CALL
Chemours
CC
$2.57B
$1.1M 0.03%
+35,000
New +$1.09M
ATC
438
CALL
DELISTED
Atotech Limited
ATC
$1.1M 0.03%
+50,100
New +$1.2M
ATC
439
PUT
DELISTED
Atotech Limited
ATC
$1.1M 0.03%
+50,000
New +$1.19M
CXT icon
440
CALL
Crane NXT
CXT
$2.97B
$1.08M 0.03%
+28,790
New +$1.04M
OVV icon
441
CALL
Ovintiv
OVV
$17B
$1.08M 0.03%
+20,000
New +$862K
GLPI icon
442
CALL
Gaming and Leisure Properties
GLPI
$12.7B
$1.07M 0.03%
+22,900
New +$1.03M
HES
443
CALL
DELISTED
Hess
HES
$1.07M 0.03%
+10,000
New +$948K
BHVN
444
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.07M 0.03%
9,000
-48,500
-84% -$6.05M
JNJ icon
445
Johnson & Johnson
JNJ
$617B
$1.06M 0.03%
6,000
-4,000
-40% -$681K
AMX icon
446
CALL
America Movil
AMX
$76B
$1.06M 0.03%
50,000
+10,000
+25% +$193K
AMX icon
447
PUT
America Movil
AMX
$76B
$1.06M 0.03%
50,000
+10,000
+25% +$193K
CLF icon
448
Cleveland-Cliffs
CLF
$6.64B
$1.05M 0.03%
+32,500
New +$741K
SRI icon
449
Stoneridge
SRI
$200M
$1.04M 0.03%
+50,000
New +$920K
MJ icon
450
CALL
Amplify Alternative Harvest ETF
MJ
$101M
$1.04M 0.03%
8,333

Similar funds

SG3 Management's Q1 2022 Portfolio in Review

As of Q1 2022, SG3 Management held 1,521 positions worth $3.56B, down 28% from $4.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

SG3 Management withdrew a net $1.11B in Q1 2022, closing 620 positions and reducing 168 holdings. Its most notable exit was Tesla, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, SG3 Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $13.5M.

  • SG3 Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 30,000 shares worth $13.5M.
  • SG3 Management added most to Bausch Health in Q1 2022, an estimated $27.4M increase.
  • SG3 Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $126M.
  • SG3 Management fully exited Tesla in Q1 2022, selling an estimated $193M.
  • SG3 Management's ten largest holdings make up 29% of its $3.56B portfolio in Q1 2022.
  • SG3 Management opened 512 new positions and closed 620 in Q1 2022.
  • SG3 Management's portfolio value fell 28% quarter-over-quarter to $3.56B.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.